CIPLA
Back to Income Statement
|
CIPLA Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Adjusted EPS | ₹51.05 | ₹34.71 | ₹31.19 | ₹29.82 | ₹19.18 |
What is the latest Earnings Per Share (EPS) of CIPLA ?
Year | Earnings Per Share (EPS) |
---|---|
Mar2024 | ₹51.05 |
Mar2023 | ₹34.71 |
Mar2022 | ₹31.19 |
Mar2021 | ₹29.82 |
Mar2020 | ₹19.18 |
How is Earnings Per Share (EPS) of CIPLA Trending?
Years | Earnings Per Share (EPS) | % Change | |
---|---|---|---|
Mar2024 | ₹51.05 | 47.08 | |
Mar2023 | ₹34.71 | 11.29 | |
Mar2022 | ₹31.19 | 4.59 | |
Mar2021 | ₹29.82 | 55.47 | |
Mar2020 | ₹19.18 | - |
Compare Earnings Per Share (EPS) of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹121,591.2 Cr | -0.1% | 0.2% | -2.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,176.0 Cr | -0.3% | -2.9% | 11.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,076.0 Cr | 0.7% | 7.4% | 48.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹113,615.0 Cr | 3.2% | 10.3% | 11.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,024.0 Cr | 2.3% | -0.5% | 13.8% | Stock Analytics | |
MANKIND PHARMA | ₹98,309.9 Cr | 1.1% | -7% | 9.7% | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | -0.1% |
0.2% |
-2.1% |
SENSEX | -1.3% |
-0.3% |
5.8% |
You may also like the below Video Courses